Current status of oral antidiabetic drug prescribing patterns based on the body mass index for Japanese type 2 diabetes mellitus patients and yearly changes in diabetologists' prescribing patterns from 2002 to 2019 (JDDM61)-Reference-Cited by-同舟云学术

Current status of oral antidiabetic drug prescribing patterns based on the body mass index for Japanese type 2 diabetes mellitus patients and yearly changes in diabetologists' prescribing patterns from 2002 to 2019 (JDDM61)

Published:2021-07-30 Issue:1 Volume:13 Page:65-73
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J of Diabetes Invest

Author:

Yagi Noriharu¹^ORCID,Komiya Ichiro¹²^ORCID,Arai Keiko³^ORCID,Oishi Mariko⁴,Fukumoto Yoshihide⁵,Shirabe Shinichirou⁶,Yokoyama Hiroki⁷^ORCID,Yamazaki Katsuya⁸,Sugimoto Hidekatsu⁹,Maegawa Hiroshi¹⁰^ORCID,

Affiliation:

1. Yagi Medical Clinic Okinawa Japan

2. Department of Internal Medicine Okinawa Medical Hospital Okinawa Japan

3. Arai Clinic Kanagawa Japan

4. Oishi Clinic Kyoto Japan

5. Fukumoto Clinic Kagoshima Japan

6. H.E.C. Science Clinic Kanagawa Japan

7. Internal Medicine Jiyugaoka Medical Clinic Hokkaido Japan

8. Kawai Clinic Ibaraki Japan

9. Sugimoto Clinic Fukuoka Japan

10. Department of Medicine Shiga University of Medical Science Shiga Japan

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.13621

Reference40 articles.

1. IDF Diabetes ATLAS 9th edn.2019. Available from:https://www.diabetesatlas.org/en/. Accessed January 11 2021.

2. The National Health and Nutrition Survey (NHNS) Japan.2016; Available from:https://www.nibiohn.go.jp/eiken/kenkounippon21/download_files/eiyouchousa/2016.pdf. Accessed January 11 2021.

3. Changes in oral antidiabetic prescriptions and improved glycemic control during the years 2002-2011 in Japan (JDDM32)

4. 50‐year history of new drugs in Japan‐the development and progress of anti‐diabetic drugs and the epidemiological aspects of diabetes mellitus;Ozawa H;Yakushigaku Zasshi,2003

5. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real‐world data from pharmacies in Japan;Journal of Diabetes Investigation;2024-09-03

2. Adherence Patterns 1 Year After Initiation of SGLT2 Inhibitors: Results of a National Cohort Study;The American Journal of Managed Care;2024-08-07

3. Effects of the switch from dulaglutide to tirzepatide on glycemic control, body weight, and fatty liver: a retrospective study;Journal of Diabetes & Metabolic Disorders;2024-07-26

4. Deciphering mortality risk of diabetes medications in heart failure patients with diabetes mellitus under triple guideline-directed medical therapy;International Journal of Cardiology;2024-07

5. Association of dipeptidyl peptidase‐4 inhibitor initiation at glycated haemoglobin <7.5% with reduced major clinical events mediated by low glycated haemoglobin variability;Diabetes, Obesity and Metabolism;2024-05-27